ANVS
Annovis Bio Inc
1.20$
+0.9%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 12 | Q1 13 | Q2 13 | Q3 13 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +13.2% | -88.3% | -67.4% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -32.7% | +238.9% | -63.9% | +1,412.3% | -52.9% | -51.3% | +0.1% | -54.7% | +0.3% | -66.7% | +37,763.0% | -91.3% | +890.6% | -79.9% | +814.7% | +97.9% | -24.0% | -24.0% | +108.9% | -2.6% | +142.6% | -22.0% | -70.3% | +393.7% | +6.1% | +67.5% | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +14.6% | -94.1% | -70.9% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +2.9% | -2.5% | -17.2% | -52.9% | -51.3% | +0.1% | -54.7% | +0.3% | -66.7% | +37,763.0% | -91.3% | +1,189.0% | -16.1% | +96.4% | +69.2% | -23.6% | -24.3% | +108.9% | -2.6% | +142.6% | -22.0% | -70.3% | +393.7% | +6.1% | +67.5% | -35.6% | -26.8% | -11.2% | -53.5% | +85.9% | +0.3% | +3.0% | +21.9% | +39.1% | +190,968.1% | -28.2% | – | |
| – | -65.8% | +11.1% | -9.0% | -59.0% | +44.5% | -34.8% | +24.3% | +16.8% | +66.0% | -20.1% | -54.6% | +375.0% | +226.5% | -47.6% | -43.8% | +68.8% | -15.5% | +107.6% | +106.1% | +2.2% | -37.6% | +21.8% | -32.6% | +37.2% | -31.4% | -31.5% | +49.9% | -15.8% | +52.7% | -14.1% | +2.3% | -26.8% | -12.7% | +3.1% | -16.5% | +135,147.7% | +83.5% | – | |
| – | -58.2% | +11.5% | -9.3% | -52.0% | +14.8% | -36.9% | +22.0% | +11.1% | +63.9% | -21.0% | +260.2% | -33.0% | +300.5% | -56.5% | +67.7% | +89.4% | -21.8% | +12.9% | +107.4% | -0.1% | +48.0% | -12.3% | -58.7% | +214.6% | -2.1% | +52.3% | -29.7% | -25.2% | -0.6% | -43.5% | +53.5% | -6.7% | -0.2% | +18.6% | +30.5% | +85.6% | -20.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -197.9% | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | -11.5% | -47.8% | -58.3% | +82,160.0% | +194.8% | +1.7% | +0.3% | -14.0% | +143.4% | -59.4% | -98.0% | -7.5% | +983.2% | +160.3% | -1.9% | +260.5% | +83.3% | +46.8% | +40.2% | +26,476.0% | -98.9% | – | – | – | – | -61.1% | -96.8% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | -2,094.3% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -100.0% | – | -107.9% | – | -33.3% | -631,917,850,100.0% | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.